Edding Genor Group Holdings Ltd

06998

Company Profile

  • Business description

    Edding Genor Group Holdings Ltd is an integrated specialty biopharmaceutical company, focusing on oncology, autoimmune diseases, cardiovascular diseases, respiratory diseases, and anti-infectives. Through the acquisition of branded drug assets from multinational pharmaceutical companies (MNCs) and licensing in development and commercialisation rights of patented drugs from international biopharmaceutical companies, it has established a portfolio of originator-branded and other drugs. The company has two reportable operating segments: Manufacturing and Distribution, which generates the maximum revenue, and Research and development. Geographically, it derives maximum revenue from the Chinese mainland, and the rest from the USA and other markets.

  • Contact

    No. 36 Doukou Road
    Room 406, Building 1
    Hengqin New Area
    Guangdong Province
    Zhuhai
    CHN

    https://www.eddingpharm.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    1,499

Stocks News & Analysis

stocks

Apple earnings: A smooth transition despite continued memory and supply headwinds

Shares fell as investors digested the latest earnings.
stocks

Big four bank holds up in weakening economic conditions

Major bank earnings hold up in challenging conditions.
stocks

Our view after Coles’ shares plunge

Shares dropped 8% after reporting results for the September 2026 quarter.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,008.9031.700.35%
CAC 408,020.3127.38-0.34%
DAX 4025,864.62116.47-0.45%
Dow JONES (US)51,762.20221.78-0.43%
FTSE 10010,638.43122.90-1.14%
HKSE23,525.97132.650.57%
NASDAQ25,357.35192.980.77%
Nikkei 22563,081.86208.25-0.33%
NZX 50 Index13,720.2621.630.16%
S&P 5007,566.2524.850.33%
S&P/ASX 2008,886.8030.300.34%
SSE Composite Index3,608.1029.93-0.82%

Market Movers